Licensed rights and other intangible assets (Tables)

6 Months Ended

Jun. 30, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Information about License Rights and Other Intangible Assets, Net

The following provides information about our license rights and other intangible assets, net (in thousands):

	June 30, 2022						December 31, 2021
	Gross						Gross
	Carrying		Accumulated				Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net
Licensed rights and intangible assets    subject to amortization:
License rights	$	40,000	$	8,333	$	31,667	$	40,000	$	6,826	$	33,174
Hormone therapy drug patents		6,161		1,363		4,798		5,834		1,042		4,792
Hormone therapy drug patents applied    and pending approval		1,936		—		1,936		2,020		—		2,020
License rights and other intangible assets    subject to amortization		48,097		9,696		38,401		47,854		7,868		39,986
Intangible assets not subject to amortization:
Trademarks/trade name rights		320		—		320		332		—		332
License rights and other intangible assets, net	$	48,417	$	9,696	$	38,721	$	48,186	$	7,868	$	40,318